US64049M2098
US64049M2098
NeoGenomics, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 2.13B EUR | 1.87B EUR | 962.03M EUR | 1.52B EUR |
Enterprise Value | 2.36B EUR | 2.17B EUR | 1.22B EUR | 1.77B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 48.22x | -- | -- | -- |
Price to Sales | 2.78x | 2.44x | 1.29x | 2.71x |
Price to Book | 2.66x | 2.38x | 1.16x | 1.81x |
EV/Revenue | 3.08x | 2.83x | 1.64x | 3.16x |
EV/EBITDA | 97.06x | 216.48x | -- | -- |
Price to FCF (P/FCF) | 48.49x | -- | -- | 188.46x |
EV/FCF | 53.78x | -- | -- | 219.5x |
FCF Yield | 2.06% | -0.39% | -0.53% | 0.53% |